Mixed mania followed by a short duration of corticosteroid administration in a patient with peripheral facial palsy: a case report

Öz

Corticosteroids are routinely used in the treatment of peripheral facial palsy. Affective symptoms have been reported as a possible side effect due to use of corticosteroids. After corticosteroid use psychiatric symptoms are often seen in the first weeks. More than half of them are seen in the first two weeks. Euphoria and hypomania are reported as the most common side effects of short-term steroid therapy and in chronic use depression is observed more frequently than mania. Lithium and olanzapine are used effectively in the management of psychosis related to the use of corticosteroids. Clinical aspects and response to olanzapine and lithium treatment have been discussed in a patient with peripherial facial palsy, who developed mixed mania due to short term use of corticosteroid treatment.

Anahtar Kelimeler

• -

Periferik yüz felci geçirmiş olan bir hastada kısa süreli kortikosteroid kullanımı sonrasında ortaya çıkan karma mani atağı: Bir olgu sunumu

Öz

Kortikosteroidler rutin olarak periferik yüz felcinin tedavisinde kullanılmaktadır. Literatürde kortikosteroid kullanımına bağlı ortaya çıkan duygulanım belirtileri yan tesir olarak bildirilmiştir. Kortikosteroid kullanımı sonrası psikiyatrik belirtiler sıklıkla ilk haftalarda görülmektedir. Yarıdan fazlası ilk iki haftada belirti vermektedir. Kısa süreli steroid tedavisinin en sık yan etkisinin öfori ve hipomani olduğu ve süregen kullanımda maniden daha çok depresyon görüldüğü bildirilmektedir. Lityum ve olanzapin kortikosteroid kullanımıyla bağlantılı psikozun engellenmesinde ve tedavisinde başarıyla kullanılmaktadır. Periferik yüz felci geçirmiş olan olgumuzda kortikosteroid kullanımı sonrasında ortaya çıkan karma maninin klinik özellikleri, olanzapin ve lityum ile tedavisine yanıt ve seyri tartışılmıştır.

Anahtar Kelimeler

• periferik yüz felci, kortikosteroid, karma mani, olanzapin, lityum

Kaynakça

1. Wada K, Yamada N, Suzuki H. Recurrent cases of corticosteroid- induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry 2000; 61:261 7.
2. Goggans FC, Weisberg LJ, Koran LM. Lithium prophylaxis of prednisone psychosis: a case report. J Clin Psychiatry 1983; 44:111- 2.
3. Brown ES, Khan DA, Suppes T. Treatment of corticosteroid- induced mood changes with olanzapine. Am J Psychiatry 1999; 156:968.
4. Genç G, Bek S, Hamamcıoğlu K. A Psychotic Attack After Steroid Therapy in Clinically Isolated Syndrome Manifesting As Optic Neuritis. Journal Of Neurological Sciences [Turkish] 2008; 25:148- 53.
5. Brown ES, Chamberlain W, Dhanani N, Paranjpe P, Carmody TJ, Sargeant M. An open-label trial of olanzapine for corticosteroid- induced mood symptoms. J Affect Disord. 2004 ;83 :277-81.
6. Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. JAMA. 1979 Mar 9;241:1011-2.
7. Bolanos SH, Khan DA, Hanczyc M, Bauer MS, Dhanani N, Brown ES. Assessment of mood states in patients receiving long-term corticosteroid therapy and in controls with patient-rated and clinician-rated scales. Ann Allergy Asthma Immunol. 2004;92:500- 505.
8. Young RC, Biggs JT, Ziegler VE. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-35.

9. Halper JP. Corticosteroids and behavioral disturbances. In: Lin AN, Paget SA, eds. Principles of Corticosteroid Therapy. London, England: Arnold; 2002:174-201.
10. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: a report of 14 cases and a review of the literature. J Affect Disord. 1983;5:319-332.
11. Wada K, Yamada N, Sato T. Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures. Psychosomatics 2001; 42:461-6.
12. Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65:549-60.
13. Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81:1361-7.
14. Nishimura K, Harigai M, Omori M, Sato E, Hara M. Blood- brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Psychoneuroendocrinology 2008; 33: 395-403.
15. Brody S. Psychiatric observations in patients treated with cortisone and ACTH. Psychosom Med. 1952;14:94-103
16. Fricchione G, Ayyala M, Holmes VF. Steroid withdrawal psychiatric syndrome. Ann Clin Psychiatry. 1989;1:99-108
17. Goldman, L.S., Goveas, J., Olanzapine treatment of corticosteroid- induced mood disorders. Psychosomatics 2002;43:495-7.
18. Tuğlu C. Antipsychotics for the treatment of bipolar disorder Bulletin of Clinical Psychopharmacology 2008; 18:50-6.
19. Shi LZ, Juarez R, Hackworth J. Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. Curr Med Res Opin 2006; 22:961-6.
20. Brown, E.S., Management of psychiatric side effects associated with corticosteroids. Expert Rev. Neurotherapeutics 2003;3:69-75.
21. Tondo L, Baldessarini RJ, Floris G. Long-term clinical effectiveness of lithium. Br J Psychiatry 2001; 41:184-90.